EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Resazurin Reduction-Based Assays Revisited: Guidelines for Accurate Reporting of Relative Differences on Metabolic Status

Beatriz Vieira-da-Silva, Miguel A R B Castanho iD

Molecules · 01.03.2023 · 28 (5) · 2283

DOI: 10.3390/molecules28052283 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Molecules, online erschienen am 01.03.2023. Verfasst von Beatriz Vieira-da-Silva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal. Hauptthemen laut MEDLINE: Oxazines, Xanthenes. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação LaCaixa, “la Caixa” Foundation and FCT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell viability and metabolic activity are ubiquitous parameters used in biochemistry, molecular biology, and biotechnological studies. Virtually all toxicology and pharmacological projects include at some point the evaluation of cell viability and/or metabolic activity. Among the methods used to address cell metabolic activity, resazurin reduction is probably the most common. At variance with resazurin, resorufin is intrinsically fluorescent, which simplifies its detection. Resazurin conversion to resorufin in the presence of cells is used as a reporter of metabolic activity of cells and can be detected by a simple fluorometric assay. UV–Vis absorbance is an alternative technique but is not as sensitive. In contrast to its wide empirical “black box” use, the chemical and cell biology fundamentals of the resazurin assay are underexplored. Resorufin is further converted to other species, which jeopardizes the linearity of the assays, and the interference of extracellular processes has to be accounted for when quantitative bioassays are aimed at. In this work, we revisit the fundamentals of metabolic activity assays based on the reduction of resazurin. Deviation to linearity both in calibration and kinetics, as well as the existence of competing reactions for resazurin and resorufin and their impact on the outcome of the assay, are addressed. In brief, fluorometric ratio assays using low resazurin concentrations obtained from data collected at short time intervals are proposed to ensure reliable conclusions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxazinesXanthenesIndicators and ReagentsFluorometry

Stichwörter der Autor:innen

UV–Vis assaycell viabilitycytotoxicityfluorometric assaymetabolic activityresazurin

Substanzen

resazurinIndicators and ReagentsOxazinesXanthenes

Autor:innen und Institutionen

  • Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

ORCID-Profile: Miguel A R B Castanho

Förderung

  • Fundação LaCaixa
  • “la Caixa” Foundation and FCT

Zitieren

APA

Vieira-da-Silva, B., & Castanho, M. A. R. B. (2023). Resazurin Reduction-Based Assays Revisited: Guidelines for Accurate Reporting of Relative Differences on Metabolic Status. Molecules, 28(5), 2283. https://doi.org/10.3390/molecules28052283

Vancouver

Vieira-da-Silva B, Castanho MARB. Resazurin Reduction-Based Assays Revisited: Guidelines for Accurate Reporting of Relative Differences on Metabolic Status. Molecules. 2023;28(5):2283. doi:10.3390/molecules28052283

BibTeX
@article{VieiradaSilva2023,
  author = {Vieira-da-Silva, Beatriz and Castanho, Miguel A R B},
  title = {Resazurin Reduction-Based Assays Revisited: Guidelines for Accurate Reporting of Relative Differences on Metabolic Status},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {5},
  pages = {2283},
  doi = {10.3390/molecules28052283}
}
Kostenlos starten →